Expedited Pfizer Vaccine Approval Procedure. BioNTech chief warns: “We must expect a difficult winter” – News from sources



[ad_1]

The European Medicines Agency has announced that it has initiated an ongoing evaluation procedure for the Pfizer BioNTech vaccine, so that when the final results of the third test phase are ready, it can introduce it into an accelerated approval process.

BioNTech chief Ugur Shahin predicts that the time the body is protected after vaccination will last up to a year. And even if the first doses leave the warehouses in December, that doesn’t mean all problems will be solved at once, says Şahin, according to Mediafax.

“Mid-December does not mean that the situation will change dramatically. We have to expect a difficult winter. It will get worse before the situation improves. From March to April we will start to feel relaxed and ideally the situation will be better controlled in the middle of next year,” he says. Ugur Şahin, CEO of BioNTech.

The results of the American company Moderna, which according to Dr. Anthony Fauci should be at least as good as those of Pfizer BioNTech, are expected soon.

Ion Cristoiu explains why the United States has recently fallen: “The victory of the progressives has shown that America can no longer be from a moral point of view what it was”

The good news also comes from Germany, where the CureVac vaccine seemed to have good results. And while Pfizer BioNTech and Moderna vaccines pose a huge logistical challenge, they need to be stored and transported at minus 75-80 degrees, CureVac can be stored for up to three months at refrigerator temperature and lasts 24 hours at room temperature.

“Obviously we feel a great responsibility, but on the other hand I am happy that we are not alone. There are several companies that will publish the results in the coming weeks and I expect many of these results to be positive, because the immune response that some candidates have reported it is good. I feel we are not alone! ”, Ugur Şahin adds.

The new coronavirus has spread across the planet. That’s why vaccination should take place in all countries of the world, to be safe. The head of the European Commission, Ursula von der Leyen, Emmanuel Macron, the head of the WHO and Melinda Gates have planned how to finance the development of vaccines and ensure their distribution to poor countries.

“France and the European Commission each donate another 100 million euros. The money will go to the ACT accelerator in an attempt to bring the COVID-19 vaccine to all countries. And our foundation continues to contribute: today we donate 70 million dollars. to fight COVID-19. 50 million will be for low-income countries and another 20 million for new vaccines, “said Melinda Gates.

.

[ad_2]
Source link